¸ðµç ȯÀÚ¸¦ ³ªÀÇ °¡Á·Ã³·³ ÃÖ¼±À» ´ÙÇØ Áø·áÇϰڽÀ´Ï´Ù
| Á¦ ¸ñ | Longitudinal Changes in Left Ventricular Geometry After Kidney Transplantation and Their Implications on Cardiovascular Risk | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2026 | ¹ßÇ¥Áö | KIDNEY MEDICINE |
| Á¦ ¸ñ | Bisphosphonates as a Tacrolimus-Sparing Strategy in Kidney Transplantation: Insights from a Retrospective Analysis | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2026 | ¹ßÇ¥Áö | YONSEI MEDICAL JOURNAL |
| Á¦ ¸ñ | Cytomegalovirus Infection in Seropositive Kidney Transplant Recipients With Diverse Immunological Risks Under Preemptive Strategy | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2025 | ¹ßÇ¥Áö | JOURNAL OF MEDICAL VIROLOGY |
| Á¦ ¸ñ | Effects of the pretransplant obesity on kidney transplant outcomes in Korea: a nationwide cohort study | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2025 | ¹ßÇ¥Áö | BMC NEPHROLOGY |
| Á¦ ¸ñ | Clinical implications of early blood transfusion after kidney transplantation | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2025 | ¹ßÇ¥Áö | SCIENTIFIC REPORTS |
| Á¦ ¸ñ | Optimum tacrolimus trough levels for enhanced graft survival and safety in kidney transplantation: a retrospective multicenter real-world evidence study | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | INTERNATIONAL JOURNAL OF SURGERY |
| Á¦ ¸ñ | Successful eculizumab treatment as an adjunctive therapy to desensitization in ABO-incompatible living donor kidney transplantation and its molecular phenotypes | ||
|---|---|---|---|
| ¹ßÇ¥³âµµ | 2024 | ¹ßÇ¥Áö | FRONTIERS IN IMMUNOLOGY |

¿¬¼¼´ë¼¼ºê¶õ½ºº´¿øÀº 1885³â H.N.¾Ë·»ÀÌ ¼¼¿î ¿ì¸®³ª¶ó ÃÖÃÊÀÇ ¼¾ç½Ä º´¿øÀÎ Á¦Áß¿ø(±¤Çý¿ø)À¸·Î ⸳µÈ ÀÌ·¡ 130³â µ¿¾È ÃÖ°íÀÇ Ã·´Ü ÀÇ·á ¼ºñ½º¸¦ Á¦°øÇϰí ÀÖ´Â Á¾ÇÕ ÀÇ·á±â°üÀÌ´Ù. ±¹³» ÃÖÃÊ·Î Áø·áÀÇ Àü¹®È¸¦ ÅëÇÑ ÀÇ·áÀÇ Áú Çâ»óÀ» À§ÇØ ÀçȰº´¿ø, ½ÉÀåÇ÷°üº´¿ø, ¾È.À̺ñÀÎÈİúº´¿ø, ¾î¸°À̺´¿ø°ú ÀÀ±ÞÁø·á¼¾ÅÍ, ±¹Á¦Áø·á¼¾ÅÍ µî Àü¹®¼¾ÅÍ, ¾ÏÀü¹®Å¬¸®´ÐÀ» ¿î¿µÇϰí ÀÖ´Ù.
¼¿ïƯº°½Ã ¼´ë¹®±¸ ¿¬¼¼·Î 50-1